Prognosis
Brazil Approves Import of China’s Sinovac Vaccine
- Butantan Institute allowed to import 6 million doses for trial
- Bolsonaro has criticized Chinese vaccine “due to its origin”
This article is for subscribers only.
Brazil’s health regulator authorized the import of a Chinese-produced vaccine after claims from President Jair Bolsonaro that the country lacked the creditability to develop a cure for the coronavirus.
The Butantan Institute, a Sao Paulo research center that has partnered with Sinovac Biotech Ltd, was granted an “exceptional” permission to bring six million doses of the unregistered Coronavac drug into the country for phase three trials, the Brazilian Health Surveillance Agency, or Anvisa, said in a statement Friday afternoon.